Serum steroid hormone levels, sex hormone-binding globulin, and body mass index in the etiology of postmenopausal breast cancer

Epidemiology

Volumn 7, Issue 1, 1996, Pages 96-100

  Lipworth, Loren ^a,b   Adami, Hans Olov ^a,b   Trichopoulos, Dimitrios ^a   Carlström, Kjell ^c   Mantzoros, Christos ^d  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b UPPSALA UNIVERSITY   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

androstenedione; breast cancer; estrone; SHBG; testosterone

Indexed keywords

ANDROSTENEDIONE; ESTRONE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADULT; AGED; ANDROSTENEDIONE BLOOD LEVEL; ARTICLE; BODY MASS; BREAST CARCINOGENESIS; BREAST CARCINOMA; CANCER INCIDENCE; CANCER RISK; ESTRONE BLOOD LEVEL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; ONSET AGE; POSTMENOPAUSE; PRIORITY JOURNAL; TESTOSTERONE BLOOD LEVEL;

EID: 0030059217     PISSN: 10443983     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001648-199601000-00017     Document Type: Article

References (67)

1. Kirschner MA. The role of hormones in the etiology of human breast cancer. Cancer 1977;39:2716-2726.
2. Cole P, Cramer D, Yen S, Paffenbarger R, MacMahon B, Brown J. Estrogen profiles of premenopausal women with breast cancer. Cancer Res 1978;38: 745-748.
3. Key TJA, Pike MC. The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer. Eur J Cancer Clin Oncol 1988; 24:29-43.
4. Bernstein L, Ross RK, Pike MC, Brown JB, Henderson BE. Hormone levels in older women: a study of post-menopausal breast cancer patients and healthy population controls. Br J Cancer 1990;61:298-302.
5. Bernstein L, Ross RK. Endogenous hormones and breast cancer risk. Epidemiol Rev 1993;15:48-65.
6. Bulbrook RD, Moore JW, Clarke GMG, Wang DY, Millis RR, Hayward JL. Relation between risk of breast cancer and biological availability of estradiol in the blood: a prospective study in Guernsey. Ann NY Acad Sci 1986;464: 378-388.
7. Toniolo P, Levitz M, Zeleniuch-Jacquotte A, Banerjee S, Koenig KL, Shore RE, Strax P, Pasternack BS. A prospective study of endogenous estrogens and breast cancer in postmenopausal women. J Natl Cancer Inst 1995;87: 190-197.
8. Wysowski DK, Comstock GW, Helsing KJ, Lau HL. Sex hormone levels in serum in relation to the development of breast cancer. Am J Epidemiol 1987;125:791-799.
9. Garland CF, Friedlander NJ, Barrett-Connor E, Khaw KT. Sex hormones and postmenopausal breast cancer: a prospective study in an adult community. Am J Epidemiol 1992;135:1220-1230.
10. Grodin MJ, Siiteri PK, MacDonald PC. Source of estrogen production in postmenopausal women. J Clin Endocrinol Metab 1973;36:207-214.
11. Siiteri PK, MacDonald PC. Role of extraglandular estrogen. In: Human Endocrinology: Handbook of Physiology. Section 7.2. New York: American Physiologic Society, 1973;615-629.
12. Adami H-O, Johansson EDB, Vegelius J, Victor A. Serum concentrations of estrone, androstenedione, testosterone and sex-hormone-binding globulin in postmenopausal women with breast cancer and in age-matched controls. Ups J Med Sci 1979;84:259-274.
13. Adami H-O, Rimsten A, Stenkvist B, Vegelius J. Influence of height, weight and obesity on risk of breast cancer in an unselected Swedish population. Br J Cancer 1977;36:787-792.
14. Breslow NE, Day NE. Statistical Methods in Cancer Research, vol. 1. The Analysis of Case-Control Studies. IARC Scientific Pub. No. 32. Lyon: International Agency for Research on Cancer, 1980.
15. Judd HL, Lucas WE, Yen SSC. Serum 17β-estradiol and estrone levels in postmenopausal women with and without endometrial cancer. J Clin Endocrinol Metab 1976;43:272-278.
16. Adami H-O, Axelsson O, Carlström K, Vegelius J, Akerstrom G. Serum levels of cortisol, dehydroepiandrosterone, dehydroepiandrosterone sulphate, estrone and prolactin after surgical trauma in postmenopausal women. Ups J Med Sci 1982;87:201-213.
17. Baird DT, Guevara A. Concentration of unconjugated estrone and estradiol in peripheral plasma in nonpregnant women throughout the menstrual cycle, castrate and postmenopausal women and in men. J Clin Endocrinol Metab 1969;29:149-159.
18. Longcope C. Adrenal and gonadal androgen secretion in normal females. Clin Endocrinol Metab 1986;15:213-228.
19. Parker LN. Adrenal Androgens in Clinical Medicine. San Diego: Academic Press, 1989.
20. International Union Against Cancer. TNM Classification of Malignant Tumors. 2nd ed. Geneva: International Union Against Cancer, 1974.
21. Drafta D, Schindler AE, Milcu SM, Keller E, Stroe E, Horodniceanu E, Balanescu I. Plasma hormones in pre- and postmenopausal breast cancer. J Steroid Biochem 1980;13:793-802.
22. Reed MJ, Cheng RW, Noel CT, Dudley HAF, James VHT. Plasma levels of estrone, estrone sulfate, and estradiol and the percentage of unbound estradiol in postmenopausal women with and without breast disease. Cancer Res 1983;43:3940-3943.
23. Reed MJ, Beranek PA, Ghilchik MW, James VHT. Estrogen production and metabolism in normal postmenopausal women and postmenopausal women with breast or endometrial cancer. Eur J Cancer Clin Oncol 1986;22:1395-1400.
24. Begg L, Kuller LH, Gutai JP, Caggiula AG, Wolmark N, Watson CO. Endogenous sex hormone levels and breast cancer risk. Genet Epidemiol 1987;4:233-247.
25. Siiteri PK, Simberg N, Murai J. Estrogens and breast cancer. Ann NY Acad Sci 1986;464:100-105.
26. Enriori CL, Orsini W, del Carmen Cremona M, Etkin AE, Cardillo LR, Reforzo-Membrives J. Decrease of circulating level of SHBG in postmenopausal obese women as a risk factor in breast cancer: reversible effect of weight loss. Gynecol Oncol 1986;23:77-86.
27. Ernster BL, Wrensch MR, Petrakis NL, King EB, Miike R, Murai J, Goodson WH, Siiteri PK. Benign and malignant breast disease: initial study results of serum and breast fluid analyses of endogenous estrogens. J Natl Cancer Inst 1987;79:949-960.
28. Jensen J, Riis BJ, Hummer L, Christiansen C. The effects of age and body composition on circulating serum oestrogens and androstenedione after the menopause. Br J Obstet Gynaecol 1985;92:260-265.
29. Secreto G, Toniolo P, Berrino F, Recchione C, Cavalleri A, Pisani P, Totis A, Fariselli G, Di Pietro S. Serum and urinary androgens and risk of breast cancer in postmenopausal women. Cancer Res 1991;51:2572-2576.
30. Grattarola R, Secreto G, Recchione C, Castellini W. Androgens in breast cancer. Am J Obstet Gynecol 1975;118:173-178.
31. McFadyen IJ, Prescott RJ, Groom GV, Forrest APM, Golder MP, Fahmy DR. Circulating hormone concentrations in women with breast cancer. Lancet 1976;1:1100-1102.
32. Rose DP, Stauber P, Thiel A, Crowley JJ, Milbrath JR. Plasma dehydroepi-androsterone sulfate, androstenedione and cortisol, and urinary free cortisol excretion in breast cancer. Eur J Cancer 1977;13:43-47.
33. Sarfaty G, Tallis GM, Murray RML, Pitt P, Gardner H, Leppard P. Hormonal concomitants of breast cancer: urinary androgen metabolites, plasma testosterone and prolactin. Proc Int Cong Endocrinol 1977;403:399-404.
34. Secreto G, Recchione C, Cavalleri A, Miraglia M, Dati V. Circulating levels of testosterone, 17β-oestradiol, luteinising hormone and prolactin in post-menopausal breast cancer patients. Br J Cancer 1983;47:269-275.
35. Chen F, Wang SS, Dai QT. A study on plasma sex hormone levels in patients with breast cancer. Chin Med J (Engl) 1985;98:507-510.
36. Hill P, Garbaczewski L, Kasumi F. Plasma testosterone and breast cancer (Letter). Eur J Cancer Clin Oncol 1985;21:1265-1266.
37. Takatani O, Kosano H, Okumoto T, Akamatsu K, Tamakuma S, Hiraide H. Distribution of estradiol and percentage of free testosterone in sera of Japanese women: preoperative breast cancer patients and normal controls. J Natl Cancer Inst 1987;79:1199-1204.
38. Adlercreutz H, Hamalainen E, Gorbach SL, Goldin BR, Woods MN, Dwyer JT. Diet and plasma androgens in postmenopausal vegetarian and omnivorous women and postmenopausal women with breast cancer. Am J Clin Nutr 1989;49:433-442.
39. Schapira DV; Kumar NB, Lyman GH. Obesity, body fat distribution, and sex hormones in breast cancer patients. Cancer 1991;67:2215-2218.
40. Poortman J, Thijssen JHH, Schwarz F. Androgen production and conversion to estrogens in normal postmenopausal women and in selected breast cancer patients. J Clin Endocrinol Metab 1973;37:101-109.
41. Teruel M, Bolufer P, Rodriguez A, Antonio P, Salabert MT. Plasma sex steroids and SHBG in patients with breast cancer and their relation to tumor oestrogen-dependency. Exp Clin Endocrinol 1989;93:37-44.
42. Wang DY, Hayward JL, Bulbrook RD. Testosterone levels in the plasma of normal women and patients with benign breast disease or with breast cancer. Eur J Cancer 1966;2:373-376.
43. Malarkey WB, Schroeder LL, Stevens VC, James AH, Lanese RR. Twenty-four-hour preoperative endocrine profiles in women with benign and malignant breast disease. Cancer Res 1977;37:4655-4659.
44. Siiteri PK, Hammond GL, Nisker JA. Increased availability of serum estrogens in breast cancer: a new hypothesis. In: Pike MC, Siiteri PK, Welsch CW, eds. Banbury Report 8. Hormones and Breast Cancer. New York: Cold Spring Harbor Laboratory, 1981;87-106.
45. Moore JW, Clark GMG, Bulbrook RD, Hayward JL, Murai JT, Hammond GL, Siiteri PK. Serum concentrations of total and non-protein-bound oestradiol in patients with breast cancer and in normal controls. Int J Cancer 1982;29:17-21.
46. Moore JW, Clark GMG, Hoare SA, Millis RR, Hayward JL, Quinlan MK, Wang DY, Bulbrook RD. Binding of oestradiol to blood proteins and aetiology of breast cancer. Int J Cancer 1986;38:625-630.
47. Langley MS, Hammond GL, Bardsley A, Sellwood RA, Anderson DC. Serum steroid binding proteins and the bioavailability of estradiol in relation to breast diseases. J Natl Cancer Inst 1985;75:823-829.
48. Jones LA, Ota DM, Gilchrist AJ, Jackson GA, Jackson PM, Kemp K, Anderson DE, McCamant SK, Bauman DH. Bioavailability of estradiol as a marker for breast cancer risk assessment. Cancer Res 1987;47:5224-5229.
49. Ota DM, Jones LA, Jackson GL, Jackson PM, Kemp K, Bauman D. Obesity, non-protein-bound estradiol levels, and distribution of estradiol in the sera of breast cancer patients. Cancer 1986;57:558-562.
50. Sulkes A, Fuks Z, Gordon A, Gross J., Sex hormone binding globulin (SHBG) in breast cancer: a correlation with obesity but not with estrogen receptor status. Eur J Cancer Clin Oncol 1984;20:19-23.
51. Anglo-Egyptian Health Agreement Collaborative Study. Serum hormone levels in breast cancer patients and controls in Egypt and Great Britain. Eur J Cancer Clin Oncol 1988;24:1329-1335.
52. Bruning PF, Bonfrer JMG, Hart AAM, van Noord PAH, van der Hoeven H, Collette HJA, Battermann JJ, de Jong-Bakker M, Nooijen WJ, de Waard F. Body measurements, estrogen availability and the risk of human breast cancer: a case-control study. Int J Cancer 1992;51:14-19.
53. Willett WC, Browne ML, Bain C, Lipnick RJ, Stampfer MJ, Rosner B, Colditz GA, Hennekens CH, Speizer FE. Relative weight and risk of breast cancer among premenopausal women. Am J Epidemiol 1985;122:731-740.
54. Hsieh C-c, Trichopoulos D, Katsouyanni K, Yuasa S. Age at menarche, age at menopause, height and obesity as risk factors for breast cancer: associations and interactions in an international case-control study. Int J Cancer 1990;46:796-800.
55. Boyd NF, McGuire V, Fishell E, Kuriov V, Lockwood G, Tritchler D. Plasma lipids in premenopausal women with mammographic dysplasia. Br J Cancer 1989;59:766-771.
56. Vigersky RA, Kono S, Sauer M, Lipsett MB, Loriaux DL. Relative binding of testosterone and estradiol to testosterone-estradiol-binding globulin. J Clin Endocrinol Metab 1979;49:899-904.
57. Nestler JE, Powers LP, Matt DW, Steingold KA, Plymate SR, Rittmaster RS, Clore JN, Blackard WG. A direct effect of hyperinsulinemia on serum sex hormone binding-globulin levels in obese women with the PCO syndrome. J Clin Endocrinol Metab 1991;72:83-89.
58. Nestler JE. SHBG: a marker for huperinsulinemia and/or insulin resistance? (Editorial). J Clin Endocrinol Metab 1993;76:273-274.
59. Bruning PF, Bonfrer JM, Van Noord PA, Hart AA, de Jong-Bakker M, Nooijen WJ. Insulin resistance and breast cancer risk. Int J Cancer 1992; 52:511-516.
60. Preziosi P, Barrett-Connor E, Papoz L, Roger M, Saint-Paul M, Nahoul K, Simon D. Interrelation between plasma sex hormone-binding globulin and plasma insulin in healthy adult women: The Telecom study. J Clin Endocrinol Metab 1993;76:283-287.
61. Von Schoultz B, Carlström K. On the regulation of sex hormone-binding globulin: a challenge of an old dogma and outlines of an alternative mechanism. J Steroid Biochem Mol Biol 1989;32:327-334.
62. Poretsky L. On the paradox of insulin induced hyperandrogenism in insulin-resistant states. Endocr Rev 1991;12:3-13.
63. Plymate SR, Matej LA, Jones RE, Friedl KE. Inhibition of sex hormone-binding globulin production in the human hepatoma (Hep G2) cell line by insulin and prolactin. J Clin Endocrinol Metab 1988;67:460-464.
64. Plymate SR, Hoop RC, Jones RE, Matej LA. Regulation of sex hormone-binding globulin production by growth factors. Metabolism 1990;39:967-970.
65. Foekens JA, Portengen H, Janssen M, Klijn JG. Insulin-like growth factor-1 receptors and insulin-like growth factor-1-like activity in human primary breast cancer. Cancer 1989;63:2139-2147.
66. Macauley VM. Insulin-like growth factors and cancer. Br J Cancer 1992;65: 311-320.
67. Papa V, Pezzino V, Costantino A, Belfiore A, Giuffrida D, Frittitta L, Vannelli GB, Brand R, Goldfine ID, Vigneri R. Elevated insulin receptor content in human breast cancer. J Clin Invest 1990;86:1503-1510.